XG8-13457-10650
5 vaccinations
1 coded response
30 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 300 / GA
- Registered
- 2021-09-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-09-25
Registered in v-safe
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-09-25
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-27
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-12-25
Survey response — 3 months, dose 3MedDRA: Fatigue, Rash, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Full body rash for 3 weeks As of today vomiting and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-27
- 2022-03-26
-
2022-07-23
Dose 4 — Pfizer-BioNTech
- 2022-09-25
-
2022-10-21
Dose 5 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-06
- 2022-11-11
- 2022-11-20
- 2022-11-25
- 2022-12-02
- 2023-01-20
- 2023-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | No |
| 2 | 2021-01-13 | Pfizer-BioNTech | No |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-07-23 | Pfizer-BioNTech | No |
| 5 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-25 | Unsuccessful |
Free text
Release 10 — 3 months, dose 3
Symptoms: Full body rash for 3 weeks As of today vomiting and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release